Board meeting on Oct 27 to approve Q2 and H1 unaudited results

Revenue growth above 20%Profit growth above 25%EBITDA margin expansionResults View source PDF Explain this filing

ACUTAAS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.1%Reaction day

₹3155.00

prior close

₹3217.60

announcement price

In-mkt

timing

Nifty Smallcap 250market-1.1%+3.2% vs market

Pharmaceuticals peers, median of 170sector-0.5%+2.6% vs sector

On the reaction day the stock moved 3.2 pts more than Nifty Smallcap 250 and 2.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.4

10m

+0.1

15m

+0.1

30m

+0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.1-1.1+3.2-0.5+2.6

Next day

-0.2-3.9+3.6-2.2+2.0

+6.2-2.8+8.9-1.1+7.2

+20.3-0.6+21.0+0.7+19.7

+17.0-0.3+17.3+1.9+15.1

+24.9+0.3+24.5+2.1+22.8

+23.1-0.3+23.4+0.9+22.2

15d

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

ACUTAAS Chemicals (formerly Ami Organics) has scheduled a board meeting for October 27, 2026 to consider and approve unaudited standalone and consolidated financial results for Q2 and the half year ended September 30, 2026. The audit committee will meet on the same day. The trading window for designated persons is closed from October 1 and will reopen on October 30, 2026, after 48 hours of results declaration.

Likely market impact

Routine pre-results intimation. Watch for actual Q2 numbers on Oct 27, which may move the stock.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹436.9 Cr	₹306.2 Cr	+42.7%
Operating profit	₹162.3 Cr	₹86.34 Cr	+87.9%
Profit after tax	₹123.1 Cr	₹71.86 Cr	+71.4%
EBITDA margin	40.3%	31.1%	+9.1 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.